Thanks to new insights related to dendritic cell vaccines, researchers are investigating a potential vaccine for MS treatment and prevention at the Baylor Institute for Immunology Research (BIIR), a division of Baylor Research Institute. If future ... Infrosoft, 4 hours ago
New Treatment for Multiple Sclerosis Being Investigated by Researchers - Med India, 3 weeks ago
The Scripps Research Institute have discovered and synthesized a new drug candidate for relapsing multiple sclerosis. According to the results from a six-month Phase 2 study of 258 multiple sclerosis patients, the drug candidate RPC1063 reduced ...MedIndia, 1 day ago Multiple Sclerosis Drug in Trials Reduces Relapse EMax Health, 1 day ago Another new drug shows promise against multiple sclerosis Consumer Affairs, 1 day ago Multiple Sclerosis new drug candidate has promise Examiner.com, 2 days ago
By Lori Clapper Biogen Idec announced clinical study results for three of its Multiple Sclerosis (MS) treatments at the sixth Triennial Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European ...Bioresearch Online, 5 days ago Genzyme announces positive results from multiple sclerosis extension study Individual.com, 5 days ago Plegridy (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients European Pharmaceutical Review, 4 days ago Teva and Active Biotech announce encouraging data from multiple sclerosis study Individual.com, 6 days ago
Acorda Therapeutics and HealthCore to Present Ampyra Data at Americas Committee for Treatment and Research in Multiple Sclerosis/European Committee for Treatment and Research in Multiple Sclerosis Meeting
Acorda Therapeutics and HealthCore will present results from a retrospective claims database study assessing use of Ampyra (dalfampridine) Extended Release Tablets, 10 mg, at the 2014 Joint Americas Committee for Treatment and Research in Multiple ...Individual.com, 1 week ago
(MarketLine via COMTEX News Network) -- Antisense Therapeutics Limited has received a patent entitled, methods for treating multiple sclerosis using antisense oligonucleotides, from the European Patent Office, or EPO, which extends coverage of the ...PredictWallStreet, 1 day ago
Review article: Current opinion | Published 23 September 2014 , doi: 10.4414/smw.2014.14012 Cite this as: Swiss Med Wkly. 2014;144:w14012 Claire Bridel a , Patrice H. Lalive a,b a Department of Clinical Neurosciences, Division of ...Swiss Medical Weekly, 8 hours ago Peglylated Interferon Maintains Benefits Through 2 Years in Treatment of Multiple Sclerosis: Presented at ECTRIMS FirstWord Pharma, 1 week ago L-Carnitine Not Effective in Treatment of Fatigue in Multiple Sclerosis: Presented at ECTRIMS FirstWord Pharma, 1 week ago
FRANKFURT (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs.Reuters, 1 month ago
BOSTON — A new study finds measurable benefit on lower-limb spasticity in patients with progressive multiple sclerosis (MS) with a tetrahydrocannabinol-cannabidiol (THC-CBD) oromucosal spray ( Sativex , GW Pharmaceuticals). "Our findings ...General Medicine eJournal, 11 hours ago Beat Spasticity in Multiple Sclerosis with Marijuana EMax Health, 3 days ago Sativex Helps MS Spasticity in Objective Tests MedPage Today, 6 days ago Kessler pilot study demonstrates benefits of wellness program for people with MS EurekAlert!, 1 day ago
Invitation - Quebec Summit on Multiple Sclerosis - Discover the latest Quebec research projects on multiple sclerosis!
MS Deepelling at the Summit - Watch our participants swoop down a seven-storey building! MONTREAL, Sept. 23, 2014 /CNW Telbec/ - Research on multiple sclerosis is progressing in leaps and bounds, and Quebec is undeniably contributing to advances ...Canada NewsWire, 14 hours ago
Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system and renders the brain ineffective in sending messages to the rest of the body. Though we know relatively little about multiple sclerosis. Recently, it has been ...Mehr News, 2 days ago Robotics competitions Iran Daily, 23 hours ago Kashan University synthesizes controlled nanostructures Iran Daily, 23 hours ago Iranians discover direct MS-diet link Iran Daily, 23 hours ago
on your WebpageAdd Widget >Get your members hooked!